Mitral valve replacement with cloth-covered composite-seat prostheses. The case for early operation.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D000743:Anemia, Hemolytic / Q000188:drug therapy; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001698:Biomedical Engineering; D004697:Endocarditis, Bacterial / Q000209:etiology; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006350:Heart Valve Prosthesis / Q000295:instrumentation / Q000401:mortality; D006461:Hemolysis; D006470:Hemorrhage / Q000453:epidemiology; D006801:Humans; D007501:Iron / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000401:mortality / Q000601:surgery*; D008946:Mitral Valve Stenosis / Q000401:mortality / Q000601:surgery*; D011093:Polyethylene Terephthalates; D011108:Polymers; D011138:Polytetrafluoroethylene; D011183:Postoperative Complications; D011336:Probability; D011379:Prognosis; D012008:Recurrence; D012826:Silicone Elastomers; D013923:Thromboembolism / Q000453:epidemiology; D013997:Time Factors
D000925:Anticoagulants; D011093:Polyethylene Terephthalates; D011108:Polymers; D012826:Silicone Elastomers; D011138:Polytetrafluoroethylene; D007501:Iron